Advanced search
Publication Cover
Hematology Volume 21, 2016 - Issue 5
Submit an article Journal homepage
1,165
Views
7
CrossRef citations to date
0
Altmetric
Hematological Malignancy

Arsenic trioxide-based therapy is suitable for patients with psoriasis-associated acute promyelocytic leukemia – A retrospective clinical study

Fei GeDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
,
Yingmei ZhangCentral Laboratory, The First Affiliated Hospital, Harbin Medical University, China
,
Fenglin CaoCentral Laboratory, The First Affiliated Hospital, Harbin Medical University, China
,
Jinmei LiDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
,
Jinxiao HouDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
,
Ping WangDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China;Department of Neonatology, The First Affiliated Hospital, Harbin Medical University, China
,
Haitao LiDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
,
Mengyuan XuDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
,
Shuchuan LiuDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
,
Limin LiDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
,
Xiaoxia LiDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
,
Shuye WangDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
,
Chengfang LvDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
,
Yanhua SuDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China
&
Jin ZhouDepartment of Hematology, The First Affiliated Hospital, Harbin Medical University, China;Central Laboratory, The First Affiliated Hospital, Harbin Medical University, ChinaCorrespondence[email protected]
 show all
Pages 287-294 | Published online: 16 Feb 2016

References

  • Wang Y, Mi Y, Li D, Xue Y, Bian S, Wang J. Acute leukemia association with psoriasis: a report on 100 patients from a single center in China. Am J Hematol. 2010;85:378–9. doi: 10.1002/ajh.21729
  • He Y, Lu X, Qiu J, Zhu T. Severe vulgaris psoriatic patients with acute myelogenous leukaemia and resolution after allogeneic bone marrow transplantation/peripheral blood stem cell transplantation. Chinese Medical Journal. 2005;118:861–5.
  • Xue Y, Lu D, Guo Y, Lin B. Specific chromosome translocations and therapy-related leukemia induced by bimolane therapy for psoriasis. Leukemia Res. 1992;16:1113–23. doi: 10.1016/0145-2126(92)90050-H
  • Au W, Yeung C. Acute promyelocytic leukemia in patients with severe psoriasis vulgaris. Leukemia Res. 2009;33:e189–90. doi: 10.1016/j.leukres.2009.05.001
  • Zhou J, Zhang Y, Li J, Li X, Hou J, Zhao Y, et al. Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia. Blood. 2010;115:1697–702. doi: 10.1182/blood-2009-07-230805
  • Guha Mazumder DN. Chronic arsenic toxicity and human health. Indian J Med Res. 2008;128:436–47.
  • Frantz CE, Smith H, Eades DM, Grosovsky AJ, Eastmond DA. Bimolane: in vitro inhibitor of human topoisomerase II. Cancer Lett. 1997;120:135–40. doi: 10.1016/S0304-3835(97)00303-0
  • Roy SK, Eastmond DA. Bimolane induces multiple types of chromosomal aberrations in human lymphocytes in vitro. Mutat Res. 2011;726:181–7. doi: 10.1016/j.mrgentox.2011.09.006
  • Vuong MC, Hasegawa LS, Eastmond DA. A comparative study of the cytotoxic and genotoxic effects of ICRF-154 and bimolane, two catalytic inhibitors of topoisomerase II. Mutat Res. 2013;750:63–71. doi: 10.1016/j.mrgentox.2012.09.005
  • Chen SQ, Xue KX, Wu JZ, Ma GJ. Mutagenic effects of bimolane. Zhongguo Yao Li Xue Bao. 1995;16:531–3.
  • Lakhani S, Davidson RN, Hiwaizi F, Marsden RA. Razoxane and leukemia. Lancet. 1984;2:288–9. doi: 10.1016/S0140-6736(84)90330-1
  • Ades L, Guerci A, Raffoux E, Sanz M, Chevallier P, Lapusan S., et al. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Blood. 2010;115:1690–6. doi: 10.1182/blood-2009-07-233387
  • O'Daly J, editor. Psoriasis – a systemic disease. Rijeka, Croatia: InTech Publishing; 2012. p. 216.
  • Zhang Y, Zhang Z, Li J, Li L, Han X, Han L., et al. Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia. Cancer. 2013;119:115–25. doi: 10.1002/cncr.27650
  • Ohnishi K, Yoshida H, Shigeno K, Nakamura S, Fujisawa S, Naito K., et al. Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring. Leukemia. 2002;16:617–22. doi: 10.1038/sj.leu.2402426
  • Westervelt P, Brown R, Adkins D, Khoury H, Curtin P, Hurd D., et al. Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood. 2001;98:266–71. doi: 10.1182/blood.V98.2.266
  • Unnikrishnan D, Dutcher J, Varshneya N, Lucariello R, Api M, Garl S., et al. Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood. 2001;97:1514–6. doi: 10.1182/blood.V97.5.1514
  • Kohn D, Flatau E, Daher O, Zucjerman F. Treatment of psoriasis with daunorubicin and cytarabine. Arch Dermatol. 1980;116:1101–2. doi: 10.1001/archderm.1980.01640340011006
  • Paslin D. Psoriasis without neutrophils. Int J Dermatol. 1990;29:37–40. doi: 10.1111/j.1365-4362.1990.tb03753.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.